General Article Biotech minnow Angle triumphs with cancer blood testing kit

Topic Selected: Biotech and Bioethics Book Volume: 352
This article is 6 years old. Click here to view the latest articles for this topic.

By Julia Bradshaw

Biotech company Angle has scored a win after its blood testing technology was central in helping doctors discover a potentially ground-breaking treatment for cancer.

The Aim-listed firm’s device, called Parsortix, is able to catch tumour cells circulating in the blood through a simple blood test.

Now researchers at Basel University Hospital in Switzerland have shown that Parsortix can also harvest tumour cells that are attached to each other in clusters, called circulating t...

Would you like to see the rest of this article and all the other benefits that Issues Online can provide with?

Sign up now for a no obligation FREE TRIAL and view the entire collection